Stanislav Ignatenko

Berlin, BE, DE 
Berlin, BE, DE 

Overview

Stanislav Ignatenko practices practicing medicine in Berlin, Germany.

His clinical expertise encompasses Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE).

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Two-part Phase I Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of Single Intravenous and Subcutaneous Doses of GSK3858279 in Healthy Participants and to Evaluate the Efficacy of Repeat Subcutaneous Doses in Participants With Osteoarthritis of the Knee
A Two-part Phase I Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of Single Intravenous and Subcutaneous Doses of GSK3858279 in Healthy Participants and to Evaluate the Efficacy of Repeat Subcutaneous Doses in Participants With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 22, 2024
Intervention Type: Drug
Study Drug: GSK3858279
Study Phase: Phase 1

12 Total Publications

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Olamkicept up to 2400 mg in Healthy Men: Phase I, Randomized, Placebo-Controlled, and Double-Blind Trial.
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Olamkicept up to 2400 mg in Healthy Men: Phase I, Randomized, Placebo-Controlled, and Double-Blind Trial.
Journal: Clinical and translational science
Published: February 06, 2026

Frequently Asked Questions about Stanislav Ignatenko

Is Stanislav Ignatenko a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Stanislav Ignatenko is classified as an Experienced expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stanislav Ignatenko participate in research or clinical trials?

Yes. Stanislav Ignatenko has published 12 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Stanislav Ignatenko's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ignatenko's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile